The transmembrane tyrosines Y56, Y91 and Y167 play important roles in determining the affinity and transport rate of the rabbit proton-coupled peptide transporter PepT1.
The mammalian proton-coupled peptide transporter PepT1 is widely accepted as the major route of uptake for dietary nitrogen, as well as being responsible for the oral absorption of a number of classes of drugs, including beta-lactam antibiotics and angiotensin-converting enzyme (ACE) inhibitors. Using site-directed mutagenesis and zero-trans transport assays, we investigated the role of conserved tyrosines in the transmembrane domains (TMDs) of rabbit PepT1 as predicted by hydropathy plots. All the individual TMD tyrosines were substituted with phenylalanine and shown to retain the ability to traffic to the plasma membrane of Xenopus laevis oocytes. These single substitutions of TMD tyrosines by phenylalanine residues did not affect the proton dependence of peptide uptake, with all retaining wild-type PepT1-like pH dependence. Individual mutations of four of the nine TMD residue tyrosines (Y64, Y287, Y345 and Y587) were without measurable effect on PepT1 function, whereas the other five (Y12, Y56, Y91, Y167 and Y345) were shown to result in altered transport function compared to the wild-type PepT1. Intriguingly, the affinity of Y56F-PepT1 was found to be dramatically increased (approximately 100-fold) in comparison to that of the wild-type rabbit PepT1. Y91 mutations also affected the substrate affinity of the transporter, which increased in line with the hydrophilicity of the substituted amino acid (F>Y>Q>R). Y167 was demonstrated to play a pivotal role in rabbit PepT1 function since Y167F, Y167R and Y167Q demonstrated very little transport function. These results are discussed with regard to a proposed mechanism for PepT1 substrate binding.
Pieri
Myrtani
M
School of Life Sciences, Oxford Brookes University, Headington, Oxford OX3 OBP, UK.
Gan
Christine
C
Bailey
Patrick
P
Meredith
David
D
D019943:Amino Acid Substitution / Q000187:drug effects / Q000235:genetics; D000818:Animals; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism*; D004151:Dipeptides / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration / Q000187:drug effects; D007700:Kinetics; D050505:Mutant Proteins / Q000378:metabolism; D009154:Mutation / Q000235:genetics; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism; D000074011:Peptide Transporter 1; D021381:Protein Transport / Q000187:drug effects; D011817:Rabbits; D013329:Structure-Activity Relationship; D027981:Symporters / Q000378:metabolism*; D014443:Tyrosine / Q000378:metabolism*; D014981:Xenopus; D014982:Xenopus laevis
D004151:Dipeptides; D050505:Mutant Proteins; D000074011:Peptide Transporter 1; D027981:Symporters; D014443:Tyrosine